ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

Gallo Group Finds Another Human Virus

November 7, 1986

In Brief: Pagano to Retire As Lineberger Director; Nursing Society Elects Yarbro As President

September 20, 1996

Richard Pazdur’s Comments to ODAC

July 22, 2011

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010